Liver Diseases  >>  Sunvepra (asunaprevir)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sunvepra (asunaprevir) / BMS
NCT01030432 / 2009-013652-69: Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Checkmark
Jul 2014 - Jul 2014: 
Checkmark APASL 2014
Mar 2014 - Mar 2014: APASL 2014
Checkmark
More
Completed
2a/2b
285
US, Europe, RoW
BMS-650032, Placebo, Pegasys, Peginterferon Alfa-2a, Ribavirin, Copegus
Bristol-Myers Squibb
Hepatitis C Virus
10/12
10/12
NCT00722358: A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Completed
2
15
US
BMS-650032, Placebo
Bristol-Myers Squibb
Chronic Hepatitis C
12/09
12/09
NCT01455090: Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications

Checkmark AASLD 2014
Oct 2014 - Oct 2014: AASLD 2014
Checkmark EASL 2014
Mar 2014 - Mar 2014: EASL 2014
Checkmark CROI 2014
More
Completed
2
320
US, Europe
BMS-650032, Asunaprevir (ASV), BMS-790052, Daclatasvir (DCV), BMS-791325, Ribavirin, Copegus®
Bristol-Myers Squibb
Chronic Hepatitis C
03/14
07/15
NCT02107365: Therapy With Asunaprevir, Daclatasvir, Ribavirin and Pegylated Interferon Alpha-2a in HCV Genotype 4-infected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (ANRS HC32 QUATTRO)

Completed
2
60
Europe
Asunaprevir, Daclatasvir, Ribavirin, Pegylated Interferon alpha-2a
ANRS, Emerging Infectious Diseases, Bristol-Myers Squibb
Hepatitis C Virus Genotype 4 Infection
02/15
04/15
QUATTROTURBO, NCT02309450: Pilot Study to Assess Efficacy and Safety of a Triple Therapy With Asunaprevir, Daclatasvir, and BMS-791325 in HCV Genotype 4-infected Patients After Failure of Pegylated Interferon-Ribavirin Regimen

Withdrawn
2
0
Europe
.Asunaprevir, Daclatasvir and BMS - 791325
ANRS, Emerging Infectious Diseases, Bristol-Myers Squibb
Hepatitis C Virus Genotype 4 Infection
11/15
08/16

Download Options